The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

This report from GlobalData will help you better understand the potential impact of Trump 2.0 on the Automotive industry.

Monde Nissin has reported narrowing losses but continued falling sales from its meat-alternatives division, which the Quorn ...

The overwhelming message of the day was the technology is too big and fast growing to ignore. Analyst Cyrus Mewawalla, head ...

Medicaid faces changes, as Trump previously proposed adding work requirements, though he has not addressed this in his ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

In Canada pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.

Slowing electric-vehicle adoption is likely to accelerate even further as President-elect Donald Trump delivers on his ...

With Trump, tariffs are likely to be a headache, tax cuts could be a tailwind, and an immigration crackdown may make hiring skilled workers harder.

With Donald Trump securing his return to the White House for a second term, we explore what his second term could mean for ...